Gerry Oster

Summary

Affiliation: Policy Analysis Inc
Country: USA

Publications

  1. ncbi Long-term mortality and medical care charges in patients with severe sepsis
    Derek Weycker
    Policy Analysis Inc, Brookline, MA, USA
    Crit Care Med 31:2316-23. 2003
  2. ncbi Dose intensification with infliximab in patients with rheumatoid arthritis
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445, USA
    Ann Pharmacother 39:2021-5. 2005
  3. ncbi Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens
    Charu Taneja
    Policy Analysis, Inc, Brookline, MA, USA
    Expert Opin Pharmacother 13:2111-8. 2012
  4. ncbi Resource utilization and costs before and after total joint arthroplasty
    Kevin J Bozic
    University of California, San Francisco, Department of Orthopaedic Surgery, San Francisco, CA 94143 0728, USA
    BMC Health Serv Res 12:73. 2012
  5. ncbi The clinical and economic burden of obesity in a managed care setting
    G Oster
    Policy Analysis, Inc PAI, Brookline, MA 02445, USA
    Am J Manag Care 6:681-9. 2000
  6. ncbi Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey
    Gerry Oster
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    J Pain 6:356-63. 2005
  7. ncbi Economic consequences of venous thromboembolism following major orthopedic surgery
    Gerry Oster
    Policy Analysis Inc, Brookline, MA 02445 7629, USA
    Ann Pharmacother 38:377-82. 2004
  8. ncbi Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia
    Ariel Berger
    Policy Analysis Inc, Four Davis Ct, Brookline, MA 02445, USA
    Am J Manag Care 16:S126-37. 2010
  9. ncbi Benefits and risks of live attenuated influenza vaccine in young children
    Gerry Oster
    Policy Analysis, Inc, Brookline, MA 02445, USA
    Am J Manag Care 16:e235-44. 2010
  10. ncbi Lifetime health and economic benefits of weight loss among obese persons
    G Oster
    Policy Analysis, Inc PAI, Brookline, Masso 02445, USA
    Am J Public Health 89:1536-42. 1999

Detail Information

Publications94

  1. ncbi Long-term mortality and medical care charges in patients with severe sepsis
    Derek Weycker
    Policy Analysis Inc, Brookline, MA, USA
    Crit Care Med 31:2316-23. 2003
    ..Hospitalization accounted for the largest component of total medical care charges. CONCLUSIONS: Mortality and economic costs are high in patients with severe sepsis, during the period of acute illness as well as subsequently...
  2. ncbi Dose intensification with infliximab in patients with rheumatoid arthritis
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445, USA
    Ann Pharmacother 39:2021-5. 2005
    ..CONCLUSIONS: Many patients with RA beginning treatment with infliximab have their frequency of infusions and/or medication dose increased within the first 12 months...
  3. ncbi Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens
    Charu Taneja
    Policy Analysis, Inc, Brookline, MA, USA
    Expert Opin Pharmacother 13:2111-8. 2012
    ..The objective of this study was to examine adherence and persistency in HIV patients initiating first-line combination antiretroviral therapy (cART) with a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen...
  4. ncbi Resource utilization and costs before and after total joint arthroplasty
    Kevin J Bozic
    University of California, San Francisco, Department of Orthopaedic Surgery, San Francisco, CA 94143 0728, USA
    BMC Health Serv Res 12:73. 2012
    ..The purpose of this study was to compare pre- and post-surgical healthcare costs in commercially insured total joint arthroplasty (TJA) patients with osteoarthritis (OA) in the United States (U.S.)...
  5. ncbi The clinical and economic burden of obesity in a managed care setting
    G Oster
    Policy Analysis, Inc PAI, Brookline, MA 02445, USA
    Am J Manag Care 6:681-9. 2000
    ..To estimate the clinical and economic burden of obesity in a managed care setting...
  6. ncbi Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey
    Gerry Oster
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    J Pain 6:356-63. 2005
    ..Our study highlights the need for improved management of this disease...
  7. ncbi Economic consequences of venous thromboembolism following major orthopedic surgery
    Gerry Oster
    Policy Analysis Inc, Brookline, MA 02445 7629, USA
    Ann Pharmacother 38:377-82. 2004
    ..Venous thromboembolism (VTE) is a frequent and potentially costly complication of major orthopedic surgery...
  8. ncbi Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia
    Ariel Berger
    Policy Analysis Inc, Four Davis Ct, Brookline, MA 02445, USA
    Am J Manag Care 16:S126-37. 2010
    ..To compare healthcare utilization and costs in the year preceding and following initial diagnosis of fibromyalgia (FM)...
  9. ncbi Benefits and risks of live attenuated influenza vaccine in young children
    Gerry Oster
    Policy Analysis, Inc, Brookline, MA 02445, USA
    Am J Manag Care 16:e235-44. 2010
    ....
  10. ncbi Lifetime health and economic benefits of weight loss among obese persons
    G Oster
    Policy Analysis, Inc PAI, Brookline, Masso 02445, USA
    Am J Public Health 89:1536-42. 1999
    ..This study estimated the lifetime health and economic benefits of sustained modest weight loss among obese persons...
  11. ncbi Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders
    Gerry Oster
    Policy Analysis, Inc, Brookline, Massachusetts 02445, USA
    Am J Geriatr Pharmacother 2:163-70. 2004
    ..Although older adults with painful neuropathic disorders (PNDs) would appear to be at elevated risk for receiving potentially inappropriate pain-related medications, the extent of such drug use in this population is unknown...
  12. ncbi Excess risk of diabetes in persons with hypertension
    Derek Weycker
    Policy Analysis Inc PAI, Brookline, MA 02445, USA
    J Diabetes Complications 23:330-6. 2009
    ..Whether, and to what extent, this risk may vary across subgroups defined on the basis of important clinical characteristics has not been well characterized...
  13. ncbi Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan
    Derek Weycker
    Policy Analysis Inc PAI, Brookline, MA 02445, USA
    Blood Press 17:5-12. 2008
    ..To describe the real-world effectiveness of amlodipine add-on therapy for hypertensive patients receiving valsartan...
  14. ncbi Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan
    Derek Weycker
    Policy Analysis Inc, Four Davis Court, Brookline, MA 02445, USA
    Blood Press Suppl 2:5-12. 2008
    ..To describe the real-world effectiveness of amlodipine add-on therapy for hypertensive patients receiving valsartan...
  15. ncbi Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
    Montserrat Vera-Llonch
    Policy Analysis Inc PAI, Four Davis Court, Brookline, MA 02445, USA
    BMC Health Serv Res 11:305. 2011
    ..To characterize healthcare resource utilization and costs in patients with metastatic lung cancer receiving chemotherapy in the US...
  16. ncbi Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer
    Thomas E Delea
    Policy Analysis Inc, Brookline, MA 02445, USA
    J Thorac Oncol 1:571-6. 2006
    ..This approach may underestimate costs if SREs indirectly increase use of other services...
  17. ncbi Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study
    Derek Weycker
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Clin Ther 31:1069-81. 2009
    ..However, there is limited information on the comparative effectiveness of these agents in clinical practice...
  18. ncbi Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445, USA
    BMC Neurol 12:8. 2012
    ..Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders (PNDs) who are under the care of general practitioners (GPs) in the UK are not well understood...
  19. ncbi Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy
    Derek Weycker
    Policy Analysis Inc, Four Davis Court, Brookline, MA 02445, USA
    Am J Clin Oncol 35:267-74. 2012
    ....
  20. ncbi Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma
    Montserrat Vera Llonch
    Policy Analysis Inc PAI, Brookline, Massachusetts 02445, USA
    J Support Oncol 5:231-5. 2007
    ..OM is associated with worse clinical and economic outcomes in multiple myeloma patients undergoing autologous HSCT following high-dose melphalan conditioning...
  21. ncbi Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany
    Ariel Berger
    Policy Analysis, Inc, Brookline, MA 02445, USA
    Curr Med Res Opin 24:2489-99. 2008
    ..To examine characteristics and patterns of healthcare utilization of patients with fibromyalgia (FM) under the care of general practitioners (GPs) in Germany...
  22. ncbi Economic impact of shifting the locus of care for neuropathic pain from specialists to general practitioners
    Ariel Berger
    Policy Analysis, Inc, Four Davis Court, Brookline, MA 02445, USA
    Eur J Health Econ 8:245-51. 2007
    ..1 million NOK (approx. US $11.9 million). A partial shift in the locus of care of painful neuropathies from specialists to GPs may result in substantial cost savings to the Norwegian health-care system...
  23. ncbi Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan
    Derek Weycker
    Policy Analysis Inc, Brookline, MA 02445, USA
    Blood Press Suppl 17:5-12. 2008
    ..CONCLUSIONS: Adding amlodipine to valsartan for treatment of hypertension results in clinically meaningful reductions in blood pressure, on an overall basis and in high-risk subgroups who may benefit the most from blood pressure control...
  24. ncbi Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice
    Thomas Delea
    Policy Analysis Inc PAI, Brookline, Massachusetts 02245 7629, USA
    J Support Oncol 4:341-7. 2006
    ..Treatments that reduce the incidence of SREs, such as intravenous bisphosphonates, should reduce these costs...
  25. ncbi Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapy
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445, USA
    Clin Ther 34:1350-63. 2012
    ..Previous studies of the use of erythropoiesis-stimulating agents (ESAs) in patients with anemia concomitant with chemotherapy may thus not reflect current clinical practice...
  26. ncbi Risk-factor clustering and cardiovascular disease risk in hypertensive patients
    Derek Weycker
    Policy Analysis, Inc, Brookline, Massachusetts 02445, USA
    Am J Hypertens 20:599-607. 2007
    ..Patients with hypertension often have other major risk factors for cardiovascular disease (CVD). Little is known, however, about the extent of risk-factor clustering in these patients and its importance in CVD risk and medical-care costs...
  27. ncbi Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease
    Ariel Berger
    Policy Analysis, Inc, Four Davis Ct, Brookline, MA 02445, USA
    Am J Manag Care 15:509-18. 2009
    ..To compare healthcare utilization and costs in patients with end-stage renal disease (ESRD) beginning peritoneal dialysis (PD) or hemodialysis (HD)...
  28. ncbi Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists
    Montserrat Vera-Llonch
    From Policy Analysis Inc, Brookline, MA 02445, USA
    J Rheumatol 35:1745-53. 2008
    ..To assess cost-effectiveness of abatacept in patients with rheumatoid arthritis (RA) with inadequate response to tumor necrosis factor-alpha antagonists (anti-TNF)...
  29. ncbi Clinical and economic characteristics of patients with painful neuropathic disorders in Germany
    Ariel Berger
    Policy Analysis Inc PAI, Brookline, Massachusetts 02445, USA
    Pain Pract 9:8-17. 2009
    ..The pain-related medications that these patients receive raise concerns that PNDs may not be optimally treated in these settings...
  30. ncbi Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy
    Montserrat Vera-Llonch
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Epilepsia 49:431-7. 2008
    ..To estimate the cost-effectiveness of pregabalin as add-on therapy in patients with refractory partial epilepsy...
  31. ncbi Opioid use and health care charges at the end of life in patients with metastatic cancer
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Manag Care Interface 17:28-34. 2004
    ..Patients receiving TF started LAO therapy closer to their date of death, and had significantly higher hospitalization charges than did patients receiving CRO and CRM...
  32. ncbi Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder
    Ariel Berger
    Policy Analysis, Inc, Brookline, USA
    BMC Geriatr 9:31. 2009
    ..The actual extent of use of these agents in clinical practice is unknown, however...
  33. ncbi Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension
    Thomas E Delea
    Policy Analysis Inc, Brookline, MA 02245, USA
    Am J Health Syst Pharm 64:1187-96. 2007
    ....
  34. ncbi Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
    Montserrat Vera-Llonch
    Policy Analysis Inc PAI, Brookline, MA, 02445, USA
    Eur J Health Econ 11:35-44. 2010
    ..We conclude that, using a new microsimulation model of the treatment of GAD, pregabalin appears to be cost-effective vs venlafaxine XR in a Spanish healthcare setting...
  35. ncbi Clinical characteristics and economic costs of patients with painful neuropathic disorders
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    J Pain 5:143-9. 2004
    ..Our study raises questions about the optimality of PND treatment in clinical practice...
  36. ncbi Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections
    John Edelsberg
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Surg Infect (Larchmt) 9:335-47. 2008
    ..Initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infection (cIAI) usually is empiric. We explored the economic consequences of failure of such therapy in this patient population...
  37. ncbi Population-wide benefits of routine vaccination of children against influenza
    Derek Weycker
    Policy Analysis Inc, Four Davis Court, Brookline, MA 02445, USA
    Vaccine 23:1284-93. 2005
    ..Similar reductions were estimated to occur in influenza-related mortality and economic costs...
  38. ncbi Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K
    Ariel Berger
    Policy Analysis Inc PAI, Brookline, Massachusetts 02445, USA
    Pain Pract 9:18-34. 2009
    ..To examine the use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners (GPs) in the U.K...
  39. ncbi Treatment of peripheral neuropathic pain: a simulation model
    Montserrat Vera-Llonch
    Policy Analysis Inc, Four Davis Court, Brookline, MA 02445, United States
    Eur J Pain 10:279-85. 2006
    ..CONCLUSIONS: When combined with data on health-state utilities and treatment costs, this new analytical tool can provide a foundation for formal cost-effectiveness evaluations of interventions for painful peripheral neuropathies...
  40. ncbi Risk of venous thromboembolism among hospitalized medically ill patients
    John Edelsberg
    Policy Analysis Inc, Brookline, MA 02445, USA
    Am J Health Syst Pharm 63:S16-22. 2006
    ..The 90-day risk of venous thromboembolism (VTE) among medically ill patients admitted to a hospital was estimated and is discussed...
  41. ncbi Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder
    Charu Taneja
    Policy Analysis Inc, Brookline, MA, USA
    Ann Pharmacother 46:642-9. 2012
    ..While the clinical utility of atypical antipsychotics has been established in patients with major depressive disorder (MDD) who are refractory to antidepressant therapy, their cost-effectiveness is unknown...
  42. ncbi Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality
    Montserrat Vera-Llonch
    Policy Analysis Inc PAI, Brookline, MA, USA
    BMC Cancer 11:250. 2011
    ..In this study, we characterize healthcare utilization and costs in the US among women with metastatic breast cancer receiving chemotherapy as their principal treatment modality...
  43. ncbi Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy
    Ariel Berger
    Policy Analysis, Inc PAI, Brookline, MA, USA
    Clin J Pain 23:251-8. 2007
    ..To describe patterns of use of tricyclic antidepressants (TCAs) (eg, amitriptyline, nortriptyline) among older patients with diabetic peripheral neuropathy (DPN)...
  44. ncbi Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis
    Ariel Berger
    Policy Analysis, Inc, Brookline, Massachusetts 02445, USA
    Arthritis Rheum 63:2268-75. 2011
    ..To examine patterns of pharmacotherapy and health care utilization and costs prior to total knee replacement (TKR) or total hip replacement (THR) in patients with osteoarthritis (OA)...
  45. ncbi Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women
    Charu Taneja
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    J Am Coll Radiol 6:171-9. 2009
    ..The aim of this study was to estimate the cost effectiveness of breast cancer screening with contrast-enhanced magnetic resonance imaging (MRI), with and without adjunctive x-ray mammography (XM), compared with XM alone in high-risk women...
  46. ncbi Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Clin Ther 25:2809-21. 2003
    ..CONCLUSION: In this study, initiation of gabapentin therapy in patients with PHN was associated with a reduction in the use of opioid analgesics...
  47. ncbi Therapy switching in patients receiving long-acting opioids
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445-7629, USA
    Ann Pharmacother 38:389-95. 2004
    ..CONCLUSIONS: Patients without cancer who receive CR oxycodone or transdermal fentanyl are less likely to switch therapy than those receiving CR morphine sulfate. Total healthcare charges are higher for patients who switch therapy...
  48. ncbi The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer
    Thomas Delea
    Policy Analysis Inc PAI, Brookline, Mass, USA
    Oncology 67:390-6. 2004
    ..These complications result in impaired mobility and reduced quality of life and have a significant negative impact on survival. The economic consequences of SREs in patients with lung cancer have not been examined...
  49. ncbi Direct and indirect economic costs among private-sector employees with osteoarthritis
    Ariel Berger
    Policy Analysis, Inc, Brookline, MA 02445, USA
    J Occup Environ Med 53:1228-35. 2011
    ..To estimate direct and indirect economic costs among private-sector employees with osteoarthritis (OA)...
  50. ncbi Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Clin Ther 30:206-18. 2008
    ..DA and EA differ, however, with respect to their assumed duration of effect and thus their approved frequency of dosing, complicating direct comparison of their doses and costs...
  51. ncbi Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil
    Derek Weycker
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Curr Med Res Opin 23:1187-97. 2007
    ..The efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease (AD) receiving stable doses of donepezil were recently demonstrated in a phase III trial. The cost-effectiveness of such therapy is unknown...
  52. ncbi Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization?
    Derek Weycker
    Policy Analysis Inc, Brookline, MA 02445, USA
    Ann Pharmacother 40:402-7. 2006
    ..In clinical practice, however, many patients receive shorter courses of therapy, even though the effectiveness of this regimen is unknown...
  53. ncbi Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study
    Thomas E Delea
    Policy Analysis, Brookline, Massachusetts 02455, USA
    Diabetes Care 26:2983-9. 2003
    ..To compare the incidence of heart failure in individuals with type 2 diabetes receiving thiazolidinediones (TZDs) versus other oral antihyperglycemic agents...
  54. ncbi Body mass index and future healthcare costs: a retrospective cohort study
    D Thompson
    Policy Analysis Inc. (PAI, Brookline, Massachusetts 02445, USA
    Obes Res 9:210-8. 2001
    ..38 (0.91 to 2.14) for inpatient care, and 1.10 (0.91 to 1.35) and 1.36 (1.11 to 1.68) for all medical care. DISCUSSION: Future healthcare costs are higher for persons who are overweight, especially those with BMIs > or = 30 kg/m(2)...
  55. ncbi Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life
    Ariel Berger
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    J Pain Symptom Manage 26:723-30. 2003
    ..8% and 31.3%, and 28.7% and 13.1%. These relatively low rates of opioid use among patients with metastatic cancer in their final year of life suggest that pain in many cases may be suboptimally treated...
  56. ncbi Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study
    Ariel Berger
    Policy Analysis Inc, Four Davis Court, Brookline, MA, 02445, USA
    BMC Psychiatry 11:193. 2011
    ..Patterns of healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder (GAD) have not been well characterized...
  57. ncbi Identification of patients receiving peritoneal dialysis using health insurance claims data
    Ariel Berger
    Policy Analysis, Inc, Brookline, Massachusetts 02445, USA
    Clin Ther 31:1321-34. 2009
    ..The aim of this analysis was to assess alternative methods of identification of patients treated with peritoneal dialysis (PD) in health care claims databases for possible use in future analyses of costs of this treatment modality...
  58. ncbi Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia
    Charu Taneja
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    J Hosp Med 5:528-34. 2010
    ..While the clinical and economic consequences of S. aureus pneumonia in healthcare settings have been well documented, much less is known about community-acquired S. aureus pneumonia (CAP)...
  59. ncbi Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention
    Thomas E Delea
    Policy Analysis Inc PAI, Brookline, MA 02245 7629, USA
    Ann Pharmacother 39:610-6. 2005
    ..01) following successful first percutaneous coronary intervention (PCI) in patients with stable or unstable angina or silent ischemia. The cost-effectiveness of such therapy is unknown...
  60. ncbi Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate
    Thomas E Delea
    Policy Analysis Inc PAI, Four Davis Court, Brookline, MA 02445, USA
    Int J Cardiol 99:117-24. 2005
    ..metoprolol tartrate in patients with heart failure. The benefits of carvedilol in typical clinical practice in the United States are unknown...
  61. ncbi Clinical and economic consequences of bleeding following major orthopedic surgery
    Montserrat Vera-Llonch
    Policy Analysis Inc. (PAI, Four Davis Court, Brookline, MA 02445, USA
    Thromb Res 117:569-77. 2006
    ..18,076 dollars). CONCLUSION: Bleeding following major orthopedic surgery may increase length of stay and total hospital charges and should be an important consideration in choice of VTE prophylaxis...
  62. ncbi Blood pressure control in patients initiating antihypertensive therapy
    Derek Weycker
    Policy Analysis Inc, Brookline, MA 02445, USA
    Ann Pharmacother 42:169-76. 2008
    ..Although information concerning the attainment of goal blood pressure for patients commencing antihypertensive therapy is available from controlled trials, no studies have examined this issue in the context of typical clinical practice...
  63. ncbi Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections
    John Edelsberg
    Policy Analysis, Brookline, Massachusetts 02445, USA
    Infect Control Hosp Epidemiol 29:160-9. 2008
    ..To estimate the consequences of failure of initial antibiotic therapy for patients with complicated skin and skin-structure infections...
  64. ncbi The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer
    Thomas E Delea
    Policy Analysis Inc. (PAI, 4 Davis Court, Brookline, MA 02245, USA
    Value Health 5:35-43. 2002
    ..The cost of inpatient care at 10.5 months was $2716 higher among 5-FU patients. CONCLUSIONS: Hospitalization for toxicity of Medicare patients with metastatic colorectal cancer receiving 5-FU is frequent and costly...
  65. ncbi Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis
    Derek Weycker
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Clin Ther 27:646-56. 2005
    ..The aim of this work was to retrospectively examine the costs of therapy with etanercept and infliximab, among patients aged > or = 65 years with rheumatoid arthritis (RA), from a health-care system perspective...
  66. ncbi Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma
    Montserrat Vera-Llonch
    Policy Analysis Inc. (PAI, Brookline, Massachusetts 02445, USA
    Cancer 106:329-36. 2006
    ..Patients with OM are at a higher risk of unplanned breaks in radiation therapy and hospitalization...
  67. ncbi Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitis
    Charu Taneja
    Policy Analysis Inc PAI, Brookline, MA 02445, USA
    J Drugs Dermatol 9:372-6. 2010
    ..Tacrolimus 0.1% and pimecrolimus 1.0% are used for short-term and noncontinuous treatment of atopic dermatitis (AD) in patients unresponsive to conventional therapies...
  68. ncbi Use of tricyclic antidepressants in older patients with painful neuropathies
    Ariel Berger
    Policy Analysis Inc. (PAI, Four Davis Court, Brookline, MA 02445, USA
    Eur J Clin Pharmacol 62:757-64. 2006
    ....
  69. ncbi Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board
    Lisa A Bellm
    IntraBiotics Pharmaceuticals, Inc, 1245 Terra Bella Avenue, Mountain View, CA 94043, USA
    Cancer Invest 20:793-800. 2002
    ..Minimally, clinical trials for OM should assess oral pain, opioid use, oral intake, and include objective assessment of OM...
  70. ncbi Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies
    Montserrat Vera Llonch
    Policy Analysis Incorporated, Four Davis Court, Brookline, MA 02445, USA
    Support Care Cancer 15:491-6. 2007
    ..To assess the relationship between oral mucositis (OM) and adverse clinical and economic outcomes in patients with hematologic malignancies receiving allogeneic hematopoietic stem-cell transplantation (HSCT)...
  71. ncbi Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain?
    John Edelsberg
    Policy Analysis Inc, Four Davis Court, Brookline, MA 02445, USA
    Eur J Pain 13:11-6. 2009
    ..Several systematic reviews of randomized controlled trials (RCTs) of drugs to treat neuropathic pain have reported summary estimates of efficacy - specifically, the number needed to treat (NNT)...
  72. ncbi Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq
    Derek Weycker
    Policy Analysis Inc PAI, Four Davis Court, Brookline, MA 02445, United States
    Vaccine 27:4930-7. 2009
    ..On an overall basis, Rotarix would reduce costs by $77.2 million (95% CI $71.5-$86.5). Similar reductions with Rotarix were estimated to occur under an assumption of incomplete immunization of children...
  73. ncbi Predictors of a medical-offset effect among patients receiving antidepressant therapy
    D Thompson
    Policy Analysis, Inc, Indianapolis, USA
    Am J Psychiatry 155:824-7. 1998
    ..Characteristics of patients receiving antidepressant therapy were examined to identify factors that may be associated with a medical-offset effect...
  74. ncbi Management of otitis media among children in a large health insurance plan
    D Thompson
    Policy Analysis, Inc, Brookline, MA 02146, USA
    Pediatr Infect Dis J 18:239-44. 1999
    ..We undertook this study to characterize medical and surgical management of otitis media...
  75. ncbi Lifetime health and economic consequences of obesity
    D Thompson
    Policy Analysis Inc, Brookline, Mass 02445, USA
    Arch Intern Med 159:2177-83. 1999
    ..Obesity is an established risk factor for several chronic diseases. The lifetime health and economic consequences of obesity for individual patients have not been documented...
  76. ncbi Cost-effectiveness of drug therapy for hypercholesterolaemia: a review of the literature
    D Thompson
    Policy Analysis Inc, Brookline, Massachusetts
    Pharmacoeconomics 2:34-42. 1992
    ..Studies to date therefore suggest that therapy with HMG-CoA reductase inhibitors (i.e. lovastatin and simvastatin) is substantially more cost-effective than treatment with bile-acid sequestrants...
  77. ncbi Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine
    D Weycker
    Policy Analysis Inc PAI, Brookline, MA 02445, USA
    J Hum Hypertens 21:374-80. 2007
    ..79, 95% CI 0.68-0.92). Our study thus corroborates the finding from VALUE that diabetes risk is lower for patients who receive valsartan versus amlodipine, and extends this finding to a 'real-world' setting...
  78. ncbi Cost of neutropenic complications of chemotherapy
    D Weycker
    Policy Analysis Inc, Brookline, MA 02445, USA
    Ann Oncol 19:454-60. 2008
    ..Cost of neutropenic complications of myelosuppressive chemotherapy has been reported to be substantial. Prior research, however, has focused on initial hospitalization only and has failed to account for follow-on care...
  79. ncbi Compliance with osteoporosis drug therapy and risk of fracture
    D Weycker
    Policy Analysis Inc PAI, Four Davis Court, Brookline, MA 02445, USA
    Osteoporos Int 18:271-7. 2007
    ..Patient compliance with osteoporosis drug therapy is often poor in clinical practice and may be associated with higher risk of fracture...
  80. ncbi Compliance with drug therapy for postmenopausal osteoporosis
    D Weycker
    Policy Analysis Inc PAI, Four Davis Court, Brookline, MA, 02445, USA
    Osteoporos Int 17:1645-52. 2006
    ..Patient compliance with pharmacotherapy for osteoporosis is typically poor in clinical practice; less frequent dosing with bisphosphonates may improve compliance...
  81. ncbi Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate
    M Vera-Llonch
    Policy Analysis Inc, Brookline, MA 02445, USA
    Rheumatology (Oxford) 47:535-41. 2008
    ..To assess cost-effectiveness of abatacept in patients with moderately to severely active RA and inadequate response to MTX...
  82. ncbi Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model
    Montserrat Vera-Llonch
    Policy Analysis Inc. (PAI, Brookline, MA 02445, USA
    Value Health 7:569-84. 2004
    ..CONCLUSIONS: Compared with risperidone, treatment with olanzapine may result in greater increases in body weight, higher rates of therapy discontinuation, and higher costs of medical-care services...
  83. ncbi The Risperidone Outcomes Study of Effectiveness (ROSE): a model for evaluating treatment strategies in typical psychiatric practice
    R Mahmoud
    Outcomes Research, Janssen Pharmaceutica, Inc, Titusville, NJ, USA
    J Clin Psychiatry 60:42-7; discussion 48. 1999
    ..We review the rationale for this type of trial and discuss the potential value of such trials in setting policy and in clinical practice...
  84. ncbi Trends in US hospital admissions for skin and soft tissue infections
    John Edelsberg
    Policy Analysis Inc, Brookline, Massachusetts 02445, USA
    Emerg Infect Dis 15:1516-8. 2009
    ..These results are consistent with recent reported increases in community-associated methicillin-resistant Staphylococcus aureus infections...
  85. ncbi Cost-effectiveness results from the US Carvedilol Heart Failure Trials Program
    M Vera-Llonch
    Policy Analysis Inc, Brookline, MA 02445-7629, USA
    Ann Pharmacother 35:846-51. 2001
    ....
  86. ncbi Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain
    A Berger
    Policy Analysis Inc. (PAI, Brookline, MA 02445, USA
    Eur J Cancer Care (Engl) 15:138-45. 2006
    ..Further research is needed to better understand reasons for this finding, as well as its potential implications for pain management in this patient population...
  87. ncbi Characteristics and healthcare costs of patients with fibromyalgia syndrome
    A Berger
    Policy Analysis, Inc, Brookline, MA 02445, USA
    Int J Clin Pract 61:1498-508. 2007
    ..To examine the characteristics and healthcare costs of fibromyalgia syndrome (FMS) patients in clinical practice...
  88. ncbi The impact of seizures and adverse effects on global health ratings
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Epilepsy Behav 11:179-84. 2007
    ..These data provide insight into the risk-benefit concerns of patients at equipoise when addressing the efficacy and AEs of AEDs...
  89. ncbi Epidemiology and outcomes of ventilator-associated pneumonia in a large US database
    Jordi Rello
    University Hospital Joan XXIII, University Rovira and Virgili, Tarragona, Spain
    Chest 122:2115-21. 2002
    ..While strategies to prevent the occurrence of VAP may not reduce mortality, they may yield other important benefits to patients, their families, and hospital systems...
  90. ncbi A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery
    Sean D Sullivan
    Department of Pharmacy and Health Services, University of Washington, Seattle, Washington 98195, USA
    Pharmacoeconomics 22:605-20. 2004
    ..To determine the cost effectiveness of fondaparinux sodium compared with enoxaparin sodium for prophylaxis against venous thromboembolism in patients undergoing major orthopaedic surgery...
  91. ncbi Response to Lamotte et Al. "A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients."
    John Edelsberg
    Diabetes Care 25:1899-900. 2002
  92. ncbi Incidence and prevalence of idiopathic pulmonary fibrosis
    Ganesh Raghu
    University of Washington Medical Center, Seattle, WA 98195 6522, USA
    Am J Respir Crit Care Med 174:810-6. 2006
    ..Idiopathic pulmonary fibrosis is a chronic interstitial lung disease of unknown etiology; its epidemiology in the United States has not been well characterized...
  93. ncbi Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients
    Daniel A Ollendorf
    Am J Health Syst Pharm 59:1750-4. 2002
    ..Patients who develop in-hospital clinical VTE following major orthopedic surgery have significantly longer stays in the 'hospital and approximately twofold higher costs of inpatient care...
  94. ncbi Clinical relevance of bleeding index
    Gerry Oster
    Arch Intern Med 163:2794; author reply 2794-5. 2003